Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout

Go back to Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout
(NASDAQ: PSTV) Delayed: 3.83 +0.05 (1.32%)
Previous Close $3.78    52 Week High
Open $3.81    52 Week Low
Day High $4.00    P/E N/A 
Day Low $3.81    EPS
Volume 64,830